| New indole tubulin assembly inhibitors cause stable arrest of mitotic progression, enhanced stimulation of natural killer cell cytotoxic activity, and repression of hedgehog … G La Regina, R Bai, A Coluccia, V Famiglini, S Pelliccia, S Passacantilli, ... Journal of medicinal chemistry 58 (15), 5789-5807, 2015 | 58 | 2015 |
| Discovery of 1, 1′-biphenyl-4-sulfonamides as a new class of potent and selective carbonic anhydrase XIV inhibitors G La Regina, A Coluccia, V Famiglini, S Pelliccia, L Monti, D Vullo, E Nuti, ... Journal of medicinal chemistry 58 (21), 8564-8572, 2015 | 46 | 2015 |
| Multitargeted imidazoles: potential therapeutic leads for Alzheimer’s and other neurodegenerative diseases AS Cornec, L Monti, J Kovalevich, V Makani, MJ James, KG Vijayendran, ... Journal of medicinal chemistry 60 (12), 5120-5145, 2017 | 45 | 2017 |
| Evaluation of oxetan-3-ol, thietan-3-ol, and derivatives thereof as bioisosteres of the carboxylic acid functional group P Lassalas, K Oukoloff, V Makani, M James, V Tran, Y Yao, L Huang, ... ACS Medicinal Chemistry Letters 8 (8), 864-868, 2017 | 40 | 2017 |
| Brain‐penetrant triazolopyrimidine and phenylpyrimidine microtubule stabilizers as potential leads to treat human African trypanosomiasis L Monti, SC Wang, K Oukoloff, AB Smith III, KR Brunden, CR Caffrey, ... ChemMedChem 13 (17), 1751-1754, 2018 | 24 | 2018 |
| Structure-Based Optimization of Quinazolines as Cruzain and TbrCATL Inhibitors E Barbosa da Silva, DA Rocha, IS Fortes, W Yang, L Monti, ... Journal of Medicinal Chemistry 64 (17), 13054-13071, 2021 | 22 | 2021 |
| Evaluation of the Structure–Activity Relationship of Microtubule-Targeting 1,2,4-Triazolo[1,5-a]pyrimidines Identifies New Candidates for Neurodegenerative … K Oukoloff, G Nzou, C Varricchio, B Lucero, T Alle, J Kovalevich, L Monti, ... Journal of medicinal chemistry 64 (2), 1073-1102, 2021 | 22 | 2021 |
| Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activity G Ehrenkaufer, P Li, EE Stebbins, MM Kangussu-Marcolino, A Debnath, ... PLoS neglected tropical diseases 14 (3), e0008150, 2020 | 22 | 2020 |
| Arylboronic acids as dual-action FAAH and TRPV1 ligands E Morera, V Di Marzo, L Monti, M Allarà, AS Moriello, M Nalli, G Ortar, ... Bioorganic & Medicinal Chemistry Letters 26 (5), 1401-1405, 2016 | 15 | 2016 |
| Long-range DNA interactions: inter-molecular G-quadruplexes and their potential biological relevance D Liano, L Monti, S Chowdhury, F Raguseo, M Di Antonio Chemical Communications 58 (92), 12753-12762, 2022 | 12 | 2022 |
| Evaluation of the analgesic effect of 4-anilidopiperidine scaffold containing ureas and carbamates L Monti, A Stefanucci, S Pieretti, F Marzoli, L Fidanza, A Mollica, S Mirzaie, ... Journal of Enzyme Inhibition and Medicinal Chemistry 31 (6), 1638-1647, 2016 | 12 | 2016 |
| Drug Discovery and Development for Kinetoplastid Diseases CR Caffrey, D Steverding, RS Ferreira, RB de Oliveira, AJ O'Donoghue, ... Burger's Medicinal Chemistry and Drug Discovery, 8th Edition 7, 255-334, 2021 | 8* | 2021 |
| Congeners Derived from Microtubule-Active Phenylpyrimidines Produce a Potent and Long-Lasting Paralysis of Schistosoma mansoni In Vitro L Monti, AS Cornec, K Oukoloff, J Kovalevich, K Prijs, T Alle, KR Brunden, ... ACS infectious diseases 7 (5), 1089-1103, 2020 | 7 | 2020 |
| Structure-activity relationship of dibenzylideneacetone analogs against the neglected disease pathogen, Trypanosoma brucei KR Francisco, L Monti, W Yang, H Park, LJ Liu, K Watkins, ... Bioorganic & medicinal chemistry letters 81, 129123, 2023 | 6 | 2023 |
| From rational design to serendipity: discovery of novel thiosemicarbazones as potent trypanocidal compounds SFP Braga, VC Santos, RP Vieira, EB da Silva, L Monti, SH Krake, ... European Journal of Medicinal Chemistry 244, 114876, 2022 | 6 | 2022 |
| G-quadruplexes mark sites of methylation instability associated with ageing and cancer J Rauchhaus, J Robinson, L Monti, M Di Antonio Genes 13 (9), 1665, 2022 | 6 | 2022 |
| Structure‐Activity Relationships, Tolerability and Efficacy of Microtubule‐Active 1,2,4‐Triazolo[1,5‐a]pyrimidines as Potential Candidates to Treat Human African … L Monti, LJ Liu, C Varricchio, B Lucero, T Alle, W Yang, I Bem‐Shalom, ... ChemMedChem 18 (20), e202300193, 2023 | 1 | 2023 |
| Front Cover: Structure‐Activity Relationships, Tolerability and Efficacy of Microtubule‐Active 1,2,4‐Triazolo[1,5‐a]pyrimidines as Potential Candidates to Treat … L Monti, LJ Liu, C Varricchio, B Lucero, T Alle, W Yang, I Bem‐Shalom, ... ChemMedChem 18 (20), e202300558, 2023 | | 2023 |
| G‐Quadruplexes as Key Transcriptional Regulators in Neglected Trypanosomatid Parasites L Monti, M Di Antonio ChemBioChem 24 (12), e202300265, 2023 | | 2023 |
| Tubulin and Microtubules as Drug Targets for Potential Cancer Chemotherapy and CNS-Directed Therapies L Monti Sapienza Università Editrice, 2022 | | 2022 |
Carlo BallatoreUC San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences在 ucsd.edu 的电子邮件经过验证
